I 
117TH CONGRESS 
1ST SESSION H. R. 5663 
To prohibit the Secretary of Health and Human Services from restricting 
direct access by health care facilities to COVID–19 monoclonal antibody 
therapies. 
IN THE HOUSE OF REPRESENTATIVES 
OCTOBER 21, 2021 
Mrs. HARSHBARGER (for herself, Mr. DESJARLAIS, Mr. BURCHETT, Mr. 
FLEISCHMANN, Mr. POSEY, Mr. BABIN, Mrs. CAMMACK, Mr. ROY, Mr. 
ROSE, Mrs. MILLER-MEEKS, Mr. PERRY, Mr. GOHMERT, Mr. MAST, Mr. 
STEUBE, Mr. JACKSON, Mr. WILLIAMS of Texas, Mr. AUSTIN SCOTT of 
Georgia, and Mr. DONALDS) introduced the following bill; which was re-
ferred to the Committee on Energy and Commerce 
A BILL 
To prohibit the Secretary of Health and Human Services 
from restricting direct access by health care facilities 
to COVID–19 monoclonal antibody therapies. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Treatment Restoration 
4
for Emergency Antibody Therapeutics Act’’ or the 
5
‘‘TREAT Act’’. 
6
VerDate Sep 11 2014 
16:18 Oct 26, 2021
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5663.IH
H5663
pamtmann on DSKBC07HB2PROD with BILLS
2 
•HR 5663 IH
SEC. 2. PROHIBITION ON RESTRICTIONS ON DIRECT AC-
1
CESS TO COVID–19 MONOCLONAL ANTIBODY 
2
THERAPIES. 
3
(a) IN GENERAL.—Notwithstanding any other provi-
4
sion of law, the Secretary of Health and Human Services 
5
(referred to in this section as the ‘‘Secretary’’) may not 
6
implement or continue in effect any policy that would re-
7
strict hospitals or other appropriate health care facilities 
8
from ordering and receiving COVID–19 monoclonal anti-
9
body therapies directly from manufacturers and distribu-
10
tors of such therapies. 
11
(b) NULLIFICATION OF CERTAIN POLICY.—Pursuant 
12
to subsection (a), effective on the date of enactment of 
13
this Act, the policy under which the Secretary required 
14
hospitals and other facilities to work through State or ter-
15
ritorial governments to receive supplies of COVID–19 
16
monoclonal antibody therapies allocated by the Secretary 
17
to such States or territories, announced by such Secretary 
18
on September 13, 2021, shall have no force or effect. 
19
Æ 
VerDate Sep 11 2014 
16:18 Oct 26, 2021
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H5663.IH
H5663
pamtmann on DSKBC07HB2PROD with BILLS
